While its overexpression promotes inflammation, tumor invasion, and metastasis, certain genetic polymorphisms in the IL1B gene (e.g., rs1143627, rs16944) have been linked to increased risk of cervical cancer, whereas others (rs3136558, rs1143630) may exert protective effects (Wang et al., 2019). This evidence concerns the gene IL1B and cervical carcinoma.